Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

The Lancet . December 06, 2022

Enlaces

https://doi.org/10.1016/S2213-8587(22)00319-9

Artículos Relacionadas

Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes

ESPEN practical guideline on clinical nutrition in acute and chronic pancreatitis

New therapies for obesity

Postmenopausal Osteoporosis

EMAS position statement: Testosterone replacement therapy in older men

2023: The year in cardiovascular disease - the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?

A literature review of evidence for primary prevention of overweight and obesity in healthy weight children and adolescents: A report produced by a working group of the Danish Council on Health and Disease Prevention

Children and adolescents in the Amsterdam Cohort of Gender Dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch Protocol

The Syndrome of Inappropriate Antidiuresis List of authors.

Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes

Agenda

Abril 2024

Lun	Mar	Mié	Jue	Vie	Sáb	Dom
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	1	2	3	4	5

Top